Myositis: Prognostic factors in 'pneumo-myositis'

Sonye K. Danoff

doi:10.1038/nrrheum.2018.55

Myositis: Prognostic factors in 'pneumo-myositis'

Sonye K. Danoff

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Interstitial lung disease (ILD) is a major cause of death and disability in patients with polymyositis or dermatomyositis. To begin to improve patient outcomes, the clinical, demographic and therapeutic factors associated with poor prognosis for patients with ILD associated with polymyositis or dermatomyositis need to be identified.

Original language	English (US)
Pages (from-to)	253-254
Number of pages	2
Journal	Nature Reviews Rheumatology
Volume	14
Issue number	5
DOIs	https://doi.org/10.1038/nrrheum.2018.55
State	Published - May 1 2018

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1038/nrrheum.2018.55

Cite this

@article{a13c7834de6c407fbc9ba4db77221863,

title = "Myositis: Prognostic factors in 'pneumo-myositis'",

abstract = "Interstitial lung disease (ILD) is a major cause of death and disability in patients with polymyositis or dermatomyositis. To begin to improve patient outcomes, the clinical, demographic and therapeutic factors associated with poor prognosis for patients with ILD associated with polymyositis or dermatomyositis need to be identified.",

author = "Danoff, {Sonye K.}",

note = "Funding Information: The work of S.K.D. is supported financially by the Huayi and Siuling Zhang Fund for Myositis. Publisher Copyright: {\textcopyright} 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.",

year = "2018",

month = may,

day = "1",

doi = "10.1038/nrrheum.2018.55",

language = "English (US)",

volume = "14",

pages = "253--254",

journal = "Nature reviews. Rheumatology",

issn = "1759-4790",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Myositis

T2 - Prognostic factors in 'pneumo-myositis'

AU - Danoff, Sonye K.

N1 - Funding Information: The work of S.K.D. is supported financially by the Huayi and Siuling Zhang Fund for Myositis. Publisher Copyright: © 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Interstitial lung disease (ILD) is a major cause of death and disability in patients with polymyositis or dermatomyositis. To begin to improve patient outcomes, the clinical, demographic and therapeutic factors associated with poor prognosis for patients with ILD associated with polymyositis or dermatomyositis need to be identified.

AB - Interstitial lung disease (ILD) is a major cause of death and disability in patients with polymyositis or dermatomyositis. To begin to improve patient outcomes, the clinical, demographic and therapeutic factors associated with poor prognosis for patients with ILD associated with polymyositis or dermatomyositis need to be identified.

UR - http://www.scopus.com/inward/record.url?scp=85045899350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045899350&partnerID=8YFLogxK

U2 - 10.1038/nrrheum.2018.55

DO - 10.1038/nrrheum.2018.55

M3 - Article

C2 - 29651120

AN - SCOPUS:85045899350

VL - 14

SP - 253

EP - 254

JO - Nature reviews. Rheumatology

JF - Nature reviews. Rheumatology

SN - 1759-4790

IS - 5

ER -

Myositis: Prognostic factors in 'pneumo-myositis'

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this